Source:http://linkedlifedata.com/resource/pubmed/id/17376414
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-4-9
|
pubmed:abstractText |
Transforming growth factor-beta (TGF-beta) participates in the pathogenesis of multiple cardiovascular diseases, including hypertension, restenosis, atherosclerosis, cardiac hypertrophy and heart failure. TGF-beta exerts pleiotropic effects on cardiovascular cells, regulating cell growth, fibrosis and inflammation. TGF-beta has long been believed to be the most important extracellular matrix regulator. We review the complex mechanisms involved in TGF-beta-mediated vascular fibrosis that includes the Smad signaling pathway, activation of protein kinases and crosstalk between these pathways. TGF-beta blockade diminishes fibrosis in experimental models, however better antifibrotic targets are needed for an effective therapy in human fibrotic diseases. A good candidate is connective tissue growth factor (CTGF), a downstream mediator of TGF-beta-induced fibrosis. Among the different factors involved in vascular fibrosis, Angiotensin II (AngII) has special interest. AngII can activate the Smad pathway independent of TGF-beta and shares with TGF-beta many intracellular signals implicated in fibrosis. Blockers of AngII have demonstrated beneficial effects on many cardiovascular diseases and are now one of the best options to block TGF-beta fibrotic responses. A better knowledge of the intracellular signals of TGF-beta can provide novel therapeutic approaches for fibrotic diseases.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-6363
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
196-206
|
pubmed:meshHeading |
pubmed-meshheading:17376414-Animals,
pubmed-meshheading:17376414-Fibrosis,
pubmed-meshheading:17376414-Heart Diseases,
pubmed-meshheading:17376414-Humans,
pubmed-meshheading:17376414-Muscle, Smooth, Vascular,
pubmed-meshheading:17376414-Signal Transduction,
pubmed-meshheading:17376414-Smad Proteins,
pubmed-meshheading:17376414-Transforming Growth Factor beta
|
pubmed:year |
2007
|
pubmed:articleTitle |
TGF-beta signaling in vascular fibrosis.
|
pubmed:affiliation |
Vascular and Renal Research Laboratory, Fundación Jiménez Diaz, Universidad Autónoma Madrid, Avda. Reyes Católicos, 2, 28040 Madrid, Spain. mruizo@fjd.es
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|